Back to RU Rubric Capital Management LP

KNSAKNSA

Showing 8 of 20 quarters

Position history for RURubric Capital Management LP's holdings in Kiniksa Pharmaceuticals International, plc

Yes. Rubric Capital Management holds 2,813,469 shares of KNSA (Kiniksa Pharmaceuticals International), worth $209.9M, as of its Q3 2026 13F filing. It reduced the position by 1,186,331 shares (-29.7%) from Q2 2026. Rubric Capital Management has held KNSA since Q2 2022, across 18 quarterly 13F filings. KNSA is 2.0% of Rubric Capital Management's reported 13F portfolio.

Current Value

$209.9M

Current Shares

2.8M

Total Value Change

+$158.1M

Total Shares Change

+194,366

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Decreased
2.8M
-29.7%
$209.9M2.0%$74.61
0
2026-Q2
Increased
4M
+6.7%
$255.8M2.3%$63.95
56
2026-Q1
Increased
3.8M
+12.7%
$180.6M1.9%$48.15
54
2025-Q4
Decreased
3.3M
-16.8%
$137.3M1.6%$41.25
0
2025-Q3
Increased
4M
+2.3%
$155.3M1.8%$38.83
49
2025-Q2
Increased
3.9M
+15.6%
$108.2M1.6%$27.67
54
2025-Q1
Increased
3.4M
+29.2%
$75.1M1.3%$22.21
59
2024-Q4
Increased
2.6M
+8.3%
$51.8M0.7%$19.78
45

Optional analytics helps us improve. How it’s used